Wolfe Research Downgrades Edwards Lifesciences (EW) to Underperform; 'risk of US TAVR disappointment'
Tweet Send to a Friend
(Updated - November 28, 2023 7:59 AM EST)
Wolfe Research analyst Mike Polark downgraded Edwards Lifesciences (NYSE: EW) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wolfe Research analyst Mike Polark downgraded Edwards Lifesciences (NYSE: EW) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
